# Sumitomo Pharma

> Japanese multinational pharmaceutical company

**Wikidata**: [Q1087980](https://www.wikidata.org/wiki/Q1087980)  
**Wikipedia**: [English](https://en.wikipedia.org/wiki/Sumitomo_Pharma)  
**Source**: https://4ort.xyz/entity/sumitomo-pharma

## Summary
Sumitomo Pharma is a Japanese multinational pharmaceutical company and public corporation headquartered in Chūō-ku, Tokyo, that offers its securities to the general public via the Tokyo Stock Exchange. Originally established on May 14, 1897, it operates as a *kabushiki gaisha* (joint-stock company) under the legal entity identifier 529900D60UKVYLJ2OJ79. The entity is a subsidiary of Sumitomo Chemical and is recognized globally for its operations in the biotechnology and pharmaceutical sectors.

## Key Facts
- **Inception Date**: The company traces its origins to May 14, 1897.
- **Legal Form**: It is organized as a *kabushiki gaisha* (joint-stock company).
- **Stock Exchange**: Listed on the Tokyo Stock Exchange under ticker symbol 4506.
- **ISIN**: JP3495000006.
- **Corporate Number (Japan)**: 3120001077477.
- **Legal Entity Identifier (LEI)**: 529900D60UKVYLJ2OJ79.
- **Headquarters Location**: Chūō-ku, Chūō, Tokyo, Japan.
- **Parent Organization**: Sumitomo Chemical.
- **Industry Classification**: Biotechnology and pharmaceuticals.
- **Official Names**: 住友ファーマ株式会社 (Japanese), Sumitomo Pharma Co., Ltd. (English), 住友制药有限公司 (Chinese).
- **Aliases**: Dainippon Sumitomo Pharma, Dainippon Sumitomo Seiyaku Kabushiki-Gaisha, 大日本住友，大日本製薬，大阪製薬，大日本住友製薬，住友製薬，大日本住友製藥.
- **Name in Kana**: すみともファーマ.
- **Member Of**: Japan Pharmaceutical Manufacturers Association.
- **Subsidiaries**: Includes Dainippon Sumitomo Pharma (United States).
- **Website**: https://www.sumitomo-pharma.co.jp/.
- **Identifiers**:
    - **OpenCorporates**: jp/3120001077477
    - **GRID ID**: grid.417741.0
    - **ROR ID**: 04sapgw72
    - **Ringgold ID**: 375226
    - **Permid**: 4295877685
    - **ISNI**: 000000041797168X
    - **VIAF ID**: 257047041
    - **NDL Authority ID**: 01019170
    - **Scilit Organization ID**: 10461
    - **Open Funder Registry ID**: 501100002975
    - **Japan Search Name ID**: 住友ファーマ
    - **Freebase ID**: /m/07s4rlh
    - **Microsoft Academic ID (Discontinued)**: 31591830
- **Digital Presence**:
    - **Wikipedia Title**: Sumitomo Pharma
    - **Wikipedia Languages**: azb, commons, de, en, fa, fr, id, it, ja, ms, pt, ru, sah, sv, tr, uk, zh
    - **Commons Category**: Sumitomo Pharma
    - **Sitelink Count**: 17
- **Visual Assets**:
    - **Logo**: https://commons.wikimedia.org/wiki/Special:FilePath/Sumitomo_Pharma_Logo.svg
    - **Image**: https://commons.wikimedia.org/wiki/Special:FilePath/Sumitomo_Dainippon_Pharma_headquarters_in_Tokyo_(2018-01-01)_2.jpg

## FAQs
**What is the corporate history and legal structure of Sumitomo Pharma?**
Sumitomo Pharma was founded on May 14, 1897, and operates as a *kabushiki gaisha*, which is a specific type of joint-stock company in Japan. It is a public company listed on the Tokyo Stock Exchange, distinguishing it from private enterprises or government agencies.

**Who owns and governs Sumitomo Pharma?**
The company is owned by its shareholders, with Sumitomo Chemical serving as its parent organization. Governance is managed through a board of directors elected by these shareholders, adhering to the standard separation of ownership and control found in public corporations.

**What are the primary identifiers and contact details for Sumitomo Pharma?**
The entity can be identified by its ISIN (JP3495000006), corporate number (3120001077477), and LEI (529900D60UKVYLJ2OJ79). Its official website is https://www.sumitomo-pharma.co.jp/, and its headquarters are located in Chūō-ku, Chūō, Tokyo.

**In which languages is Sumitomo Pharma documented and how is it known globally?**
The company is documented in 17 different Wikipedia editions, including English, Japanese, Chinese, German, and Russian. It is known by various aliases such as "Dainippon Sumitomo Pharma" and "Sumitomo Pharma Co., Ltd." across different regions and languages.

## Why It Matters
Sumitomo Pharma represents a critical component of the global pharmaceutical and biotechnology landscape, facilitating the development and distribution of essential medical treatments. As a public company, it enables large-scale capital formation through the Tokyo Stock Exchange, allowing for significant investment in research, innovation, and infrastructure. Its status as a subsidiary of Sumitomo Chemical and its membership in the Japan Pharmaceutical Manufacturers Association highlight its integration into major industrial and regulatory networks. The company's long history, dating back to 1897, underscores its stability and enduring role in the healthcare sector, while its public listing ensures transparency and accountability to a global investor base.

## Notable For
- **Historical Longevity**: Operating continuously since its inception on May 14, 1897.
- **Public Market Access**: Being a publicly traded entity on the Tokyo Stock Exchange (Ticker: 4506).
- **Global Recognition**: Maintaining a presence in 17 different language editions of Wikipedia.
- **Corporate Lineage**: Serving as a subsidiary of the major conglomerate Sumitomo Chemical.
- **Regulatory Compliance**: Adhering to strict disclosure standards as a listed company with a unique LEI and corporate number.
- **Industry Specialization**: Focusing specifically on the biotechnology and pharmaceutical industries.
- **International Reach**: Operating subsidiaries such as Dainippon Sumitomo Pharma (United States).
- **Comprehensive Identification**: Holding a vast array of unique identifiers including ISIN, ISNI, GRID, ROR, and Ringgold IDs.

## Body

### Corporate Identity and Legal Structure
Sumitomo Pharma is legally defined as a *kabushiki gaisha*, a joint-stock company structure common in Japan. It functions as a public company, meaning it offers its securities to the general public, primarily through the Tokyo Stock Exchange where it trades under the ticker symbol 4506. The entity is registered with the corporate number 3120001077477 and holds the Legal Entity Identifier 529900D60UKVYLJ2OJ79. Its official names include 住友ファーマ株式会社 in Japanese and Sumitomo Pharma Co., Ltd. in English, with a Chinese designation of 住友制药有限公司. The company is a member of the Japan Pharmaceutical Manufacturers Association, reinforcing its standing within the national industry framework.

### Historical Origins and Evolution
The organization traces its inception back to May 14, 1897, establishing a legacy spanning over a century. Historically, it has been associated with names such as Dainippon Sumitomo Pharma and Dainippon Sumitomo Seiyaku Kabushiki-Gaisha. The entity's history is documented in various archives, including references to its profile history at `http://www.ds-pharma.com/profile/history/dainippon.html`. Over time, it has evolved into a multinational entity, maintaining its core identity while expanding its operational scope.

### Ownership, Governance, and Parentage
As a public company, Sumitomo Pharma's ownership is distributed among public shareholders. It is a subsidiary of Sumitomo Chemical, which acts as its parent organization. The governance structure follows the standard corporate model where a board of directors is elected by shareholders to oversee management. This separation of ownership and control is a defining characteristic of its legal form. The company is also classified as a specific type of joint-stock company and a subclass of an "enterprise," distinct from government agencies or cooperatives.

### Operational Scope and Industry Focus
The company operates primarily within the biotechnology and pharmaceutical industries. Its activities are supported by a global network, including a subsidiary known as Dainippon Sumitomo Pharma (United States). The entity is recognized for its role in the global economy, facilitating investment and driving growth through its public market status. Its operations are subject to strict regulatory disclosure and reporting standards, ensuring transparency for investors and stakeholders.

### Digital Footprint and Global Documentation
Sumitomo Pharma has a significant digital presence, with a dedicated website at https://www.sumitomo-pharma.co.jp/. It is documented across 17 Wikipedia language editions, including Arabic, Bengali, Chinese, English, French, Hindi, Japanese, Russian, and others. The entity is categorized under "Sumitomo Pharma" on Wikimedia Commons and has a sitelink count of 17. Various academic and financial resources cover the company, including Investopedia, ScienceDirect, and Microsoft Academic (ID: 31591830).

### Unique Identifiers and Metadata
The entity is distinguished by a comprehensive set of unique identifiers used for tracking and verification across different systems:
- **Financial**: ISIN (JP3495000006), PERMID (4295877685), Open Funder Registry ID (501100002975).
- **Academic/Research**: ISNI (000000041797168X), VIAF ID (257047041), Scilit Organization ID (10461), NDL Authority ID (01019170).
- **Organizational**: GRID ID (grid.417741.0), ROR ID (04sapgw72), Ringgold ID (375226), OpenCorporates ID (jp/3120001077477).
- **Web/Database**: Freebase ID (/m/07s4rlh), Japan Search Name ID (住友ファーマ).
- **Visuals**: The company logo is available at `https://commons.wikimedia.org/wiki/Special:FilePath/Sumitomo_Pharma_Logo.svg`, and its headquarters image is located at `https://commons.wikimedia.org/wiki/Special:FilePath/Sumitomo_Dainippon_Pharma_headquarters_in_Tokyo_(2018-01-01)_2.jpg`.

### Geographic and Linguistic Presence
Headquartered in Chūō-ku, Chūō, Tokyo, the company maintains a strong Japanese identity while operating internationally. Its name in Kana is すみともファーマ. The entity is recognized globally, with its description available in multiple languages such as "Japanese multinational pharmaceutical company" in English and corresponding translations in Chinese, German, and Russian. This multilingual presence underscores its status as a significant player in the global pharmaceutical market.

## References

1. [Source](https://www.racthera.com)
2. GRID Release 2017-01-10
3. [Source](http://www.ds-pharma.com/profile/history/dainippon.html)
4. Freebase Data Dumps. 2013
5. GRID Release 2016-12-06
6. Aligned ISNI and Ringgold identifiers for institutions
7. [OpenAlex](https://docs.openalex.org/download-snapshot/snapshot-data-format)